OssDsign

OssDsign Current Liabilities

The Current Liabilities of OssDsign (OSSD.ST) as of Nov 3, 2026 is 55.16 M SEK. In the previous year, Current Liabilities was 59.59 M SEK — a change of -7.43% (lower).

Current Liabilities

55.16 MSEK

YoY

-7.43%

Last updated:

Current Liabilities of OssDsign is 2025 55.16 M SEK. Current Liabilities of OssDsign was 2024 59.59 M SEK. It decreases by -7.43% lower compared to the previous year.

The OssDsign Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
28.31 M SEK
Jan 1, 2019
23.90 M SEK
Jan 1, 2020
72.21 M SEK
Jan 1, 2021
35.79 M SEK
Jan 1, 2022
64.40 M SEK
Jan 1, 2023
81.56 M SEK
Jan 1, 2024
59.59 M SEK
Jan 1, 2025
55.16 M SEK
The OssDsign Current Liabilities history
YEARCurrent LiabilitiesYoY
55.16 MSEK-7.43%
59.59 MSEK-26.94%
81.56 MSEK+26.64%
64.40 MSEK+79.93%
35.79 MSEK-50.43%
72.21 MSEK+202.15%
23.90 MSEK-15.59%
28.31 MSEK+52.95%
18.51 MSEK+180.65%
6.60 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OssDsign Stock analysis

What does OssDsign do? OssDsign AB develops and sells medical technology products, focusing on implantable solutions for bone healing, particularly in skull surgery. Its primary product, Craniomosaic, is an implant for skull defect repair (cranioplasty), while it also develops bioceramic implants for facial bone augmentation. The company uses proprietary bioceramic technologies that integrate with tissues and support bone ingrowth. Customers include neurosurgeons, craniofacial, and maxillofacial surgeons who purchase these products for surgical procedures. The company generates revenue through the development and sales of its medical technology products, specifically Craniomosaic and bioceramic implants for facial bone augmentation. These products are sold to surgeons specializing in skull and facial bone procedures. The firm’s focus on proprietary bioceramic technologies differentiates its offerings in the medical device market, targeting healthcare professionals who require advanced solutions for bone healing challenges. OssDsign AB’s business model centers on selling implantable medical devices developed using its unique bioceramic technologies. The company’s main customers are neurosurgeons, craniofacial surgeons, and maxillofacial surgeons who use Craniomosaic and facial bone augmentation implants during surgical operations. Revenue is derived from the direct sale of these products to medical professionals for clinical applications in bone healing and reconstruction. OssDsign is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OssDsign stock

Current Liabilities of OssDsign is 55.16 M SEK in 2025.

Current Liabilities of OssDsign changed from 59.59 M SEK to 55.16 M SEK, representing a -7.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities OssDsign since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's OssDsign historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — OssDsign

All Key Metrics — OssDsign